Can Carl Icahn Perform a Hat Trick with Transocean?

Jacob is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.

Personal care products company Herbalife (NYSE: HLF) made headlines the other day after the company’s board approved two of billionaire investor Carl Icahn's designees to its board.

The size of the board will increase to 11 from 9 to accommodate Icahn’s nominees. Icahn has also been given the option of boosting his stake to 25 percent from the current 13.6 percent. The stock moved up as a result, but the real winner here is Icahn, whose interest in the company placed it in a winning position against arch rival Bill Ackman.

Ackman, manager of the hedge fund Pershing Square Capital Management, has an exceptionally large short position in Herbalife. By some accounts, Pershing Square made a $1 billion bet on the fall in Herbalife shares. Ackman has even gone so far as to have labeled Herbalife a pyramid scheme.

However, Herbalife’s stock has gone up more than 11 percent so far this week, effectively nullifying Ackman’s short position. While Ackman must be busy calculating his fund’s loss, Icahn took the opportunity to rub some salt on the bruised ego. "[Bill Ackman] has given us the opportunity to buy a company at a discount...and for that, I thank him," said Icahn in an interview.

Herbalife is not exactly a company with exceptional growth attributes, though it remains a profitable entity at what it does. Icahn’s investment follows on the heels of fellow hedge fund investor Daniel Loeb’s decision of cutting his exposure to the company.

Loeb’s fund had an 8.2 percent stake in the company on Jan. 9. However, there is a big difference in the investment approaches as Loeb remains largely content as a passive investor. Icahn, on the other hand, is a difficult-to-please activist investor who, after setting his eyes on a company, pushes for major overhauls to unlock shareholder value. In the process, he seems to have made more enemies than friends.

While Herbalife’s rally has largely played out, Icahn has positions in several other companies that have  yet to unfold. Transocean (NYSE: RIG) is one such company in which Icahn has an interest in. Icahn Enterprises reported in January that Icahn and his affiliates had acquired a 1.5 percent stake in the deep water driller and were seeking to expand the stake to more than 3 percent.

Icahn’s intention of buying the stake is not clear, but it is expected to be substantially different from the objectives seen in Herbalife. The company’s shares currently trades at a substantial discount to its April 2010 levels when it used to trade around $85. Transocean was the rig contractor of the ill-fated oil well in the Gulf of Mexico which experienced the massive spill that nearly wiped out all the profits from its balance sheet for two years. Earlier in January, the company agreed to pay $1.4 billion in penalties for its role in the maritime disaster.

Icahn has meaningful experience working with oil companies, which means he knows what buttons he needs to push. Last year, Icahn acquired more than an 80 percent equity stake in the Texas based oil refiner CVR Energy (NYSE: CVI) through a tender offer. CVR Energy is a player with relatively solid margins, but Icahn failed to find a suitor for the refiner largely due to the fact that most existing players didn't want to make an acquisition.

Meanwhile, CVR Energy has continued to perform better and its stock price continues to go up. For the latest quarter, CVR Energy managed to double its profits to $208 million, as revenues grew 78.3 percent.

Whether Transocean becomes another Herbalife in terms of stock performance or not remains a question best left to time. However, Icahn has just started started building a stake in Transocean. Coupled with the company’s depressed stock price, the opportunity to strike big with this stock is possible.


valuewalk has no position in any stocks mentioned. The Motley Fool owns shares of Transocean and has the following options: Long Jan 2014 $50 Calls on Herbalife Ltd.. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. Is this post wrong? Click here. Think you can do better? Join us and write your own!

blog comments powered by Disqus